These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31848258)

  • 1. Motor function decline correlates with behavioral impairment in
    Gandhy S; Farren J; Floeter MK
    Neurology; 2020 Jan; 94(3):134-136. PubMed ID: 31848258
    [No Abstract]   [Full Text] [Related]  

  • 2. Two mutations, one family: C9orf72 and SQSTM1 in neurodegenerative diseases.
    Henegan P; Chysna K; Essad K; Stommel E
    J Neurol Sci; 2019 Oct; 405():116420. PubMed ID: 31445297
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the
    Devenney EM; Landin-Romero R; Irish M; Hornberger M; Mioshi E; Halliday GM; Kiernan MC; Hodges JR
    Neuroimage Clin; 2017; 13():439-445. PubMed ID: 28116236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
    Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
    Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease progression in
    Floeter MK; Traynor BJ; Farren J; Braun LE; Tierney M; Wiggs EA; Wu T
    Neurology; 2017 Jul; 89(3):234-241. PubMed ID: 28615433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C9orf72 expansion presenting as an eating disorder.
    Sanders P; Ewing I; Ahmad K
    J Clin Neurosci; 2016 Mar; 25():157-9. PubMed ID: 26547294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene.
    Calvo A; Moglia C; Canosa A; Cistaro A; Valentini C; Carrara G; Soldano E; Ilardi A; Bersano E; Bertuzzo D; Brunetti M; Ossola I; Restagno G; Chiò A
    J Neurol; 2012 Dec; 259(12):2723-5. PubMed ID: 22918453
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychiatric presentations of amyotrophic lateral sclerosis].
    Kutlubaev MA; Pervushina EV; Areprintceva DK; Mendelevich VD; Brylev LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5):36-42. PubMed ID: 35611898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of C9ORF72 in amyotrophic lateral sclerosis correlates with brain-computer interface performance.
    Geronimo A; Sheldon KE; Broach JR; Simmons Z; Schiff SJ
    Sci Rep; 2017 Aug; 7(1):8875. PubMed ID: 28827593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population.
    Umoh ME; Fournier C; Li Y; Polak M; Shaw L; Landers JE; Hu W; Gearing M; Glass JD
    Neurology; 2016 Sep; 87(10):1024-30. PubMed ID: 27488601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the FTD-ALS associated C9orf72 expansion in suicide victims.
    Solje E; Riipinen P; Helisalmi S; Särkioja T; Laitinen M; Hiltunen M; Hakko H; Remes AM
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):589-592. PubMed ID: 27388677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
    Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
    Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficits in verbal fluency in presymptomatic
    Lulé DE; Müller HP; Finsel J; Weydt P; Knehr A; Winroth I; Andersen P; Weishaupt J; Uttner I; Kassubek J; Ludolph AC
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1195-1200. PubMed ID: 32855285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of the C9orf72 expansion in a Brazilian population.
    Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
    Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.